Owlet’s Dream Sock Receives Approval from CDSCO for Distribution in India 

Key Highlights: 

• Owlet announced that the Central Drugs Standard Control Organization has approved its wearable infant monitoring device, the Dream Sock, enabling the company to distribute its smart baby monitoring solutions in India. 

• Following the approval, Owlet plans to launch its integrated monitoring ecosystem in India in early 2026, including Dream Sock, Dream Sight, and Dream Duo. The devices provide real-time monitoring of key infant vitals such as oxygen levels, pulse rate, sleep patterns, and environmental activity. 

• Designed for infants aged 0–18 months, the wearable sock works alongside the Owlet Dream App to deliver real-time alerts and insights to parents. With more than 23M births expected in India in 2025 and increasing smartphone adoption, the company sees the country as a key growth market for connected infant health technologies. 

Implications:  

Dream Sock storms India’s connected parenting market, handing anxious new moms clinical-grade reassurance that traditional monitors can’t match. 
Tier-1 pediatricians embrace wearable vitals as standard newborn care, exploding daily app engagement while hospitals recommend for high-risk infants. 
Owlet ignites premium baby tech category, capturing affluent urban families as digital health reshapes early childhood monitoring nationwide. 

Source: Businesswire | Image: Owlet